Volume 2, Issue 2, March 2014, Page: 10-14
Pyelonephritis in Adult Women with Homozygous Sickle Cell Disease: about 42 Cases
Sekongo Yassongui Mamadou, National Blood Transfusion Center (NBTC), Abidjan, Côte d’Ivoire;Clinical Hematology, Yopougon Teaching Hospital, Abidjan, Côte d’Ivoire;Genetic disease unit of red blood cell (UMGGR), Hospital Henri Mondor, Créteil, France
Abisse Agba, National Blood Transfusion Center (NBTC), Abidjan, Côte d’Ivoire
Tolo-Diebkile Aissata, Clinical Hematology, Yopougon Teaching Hospital, Abidjan, Côte d’Ivoire
Konan Sidoine, National Blood Transfusion Center (NBTC), Abidjan, Côte d’Ivoire
Kouamenan Sidonie, National Blood Transfusion Center (NBTC), Abidjan, Côte d’Ivoire
Danho Nanho Clotaire, Clinical Hematology, Yopougon Teaching Hospital, Abidjan, Côte d’Ivoire
Dora B., Genetic disease unit of red blood cell (UMGGR), Hospital Henri Mondor, Créteil, France
Kassougue Kadidia, National Blood Transfusion Center (NBTC), Abidjan, Côte d’Ivoire
N’Guessan Koutoua Parfait, National Blood Transfusion Center (NBTC), Abidjan, Côte d’Ivoire
Konate Seidou, National Blood Transfusion Center (NBTC), Abidjan, Côte d’Ivoire
Galacteros F., National Blood Transfusion Center (NBTC), Abidjan, Côte d’Ivoire
Received: Feb. 3, 2014;       Published: Mar. 10, 2014
DOI: 10.11648/j.ajim.20140202.11      View  2992      Downloads  124
Abstract
Sickle cell disease is a condition with 3 parts of speech including infectious complications. They are essentially encapsulated bacterial organisms. There is a significant incidence of urinary infections to adults with sickle cell disease most particularly among women. The frequency and characteristics of pyelonephritis in women with sickle cell disease is poorly understood to this day, it seemed interesting to analyze over a period of one year, the profile of sickle cell patients followed in the genetic disease unit of red blood cell Hospital Henri Mondor, Créteil, and who took at least one episode of pyelonephritis. Patients and Methods: This study was conducted in the genetic disease unit of red blood cell (UMGGR) Hospital Henri Mondor in Créteil (France). This is a retrospective descriptive and analytical study on patients with homozygous sickle cell disease, females, aged 18 years or more. The selection was conducted over a period of one year from February 2007 to February 2008. Data were collected from medical records and from reports of record of each patient. We considered the clinical, paraclinical and therapeutic latest episode of pyelonephritis. Data processing was done using the software Statview. Results: The prevalence of pyelonephritis in women with sickle cell disease aged over 15 years was 6.12% annually. The median age at first episode of pyelonephritis was 23.5 years. The majority (71.42%) was the first episode after 20 years. Among the factors predisposing to pyelonephritis, pregnancy has been implicated in 16.7% of cases. The symptoms of cystitis, with 52.4%, were the fact favoring predominant. The average number episodes of pyelonephritis to our patients were 2. The risk of recurrent pyelonephritis was significantly correlated statistically with the presence of cholelithiasis (p = 0.04). Fever was the clinical symptoms that prompted the consultation in 95.24% cases. The consequences of sickle cell disease were important. We identified 16.7% cases of sepsis and 16.7% of worsening anemia requiring transfusion. The causative agent was E. coli in 85.7% of patients. 61.9% of patients received combination therapy. The intravenous therapy as first-line was found in 81%. Fluoroquinolones were the molecules widely used in 71.4% of cases. The rate of clinical failure at 3 days of antibiotics was 4.76%. The average time for obtaining apyrexia was 3 days. The average duration of treatment was 15 days. We observed no cases of death secondary to the episode of pyelonephritis. Conclusion: This preliminary work has highlighted the incidence of pyelonephritis in women adult with sickle cell and the the potential impact on sickle cell disease. Despite being underestimated because of the retrospective nature and short duration (1 year) of study, this frequency must motivate strategy to encourage more active educational preventive towards patients and early diagnosis of urinary tract infections to women with sickle cell disease.
Keywords
Pyelonephritis, Adult Women, Homozygous Sickle Cell Disease
To cite this article
Sekongo Yassongui Mamadou, Abisse Agba, Tolo-Diebkile Aissata, Konan Sidoine, Kouamenan Sidonie, Danho Nanho Clotaire, Dora B., Kassougue Kadidia, N’Guessan Koutoua Parfait, Konate Seidou, Galacteros F., Pyelonephritis in Adult Women with Homozygous Sickle Cell Disease: about 42 Cases, American Journal of Internal Medicine. Vol. 2, No. 2, 2014, pp. 10-14. doi: 10.11648/j.ajim.20140202.11
Reference
[1]
Zarouk V., P. Lesprit. Infection in adult with sickle cell disease. In The Sickle Cell Disease, 2003 : 117-123
[2]
Zarrouk V., Habibi A., Zahar Jr., Roubot-Thoraval F., Bachir D., et al. Bloodstream infection in adults with Sickle Cell Disease. Association with venous cathethers, staphylococcus aureus, and bone-joint infections. Med. 2006, 85; 1: 43-47.
[3]
Fort A, Morrisson J, Borreras L, Diggs L, Fish S. conseling the patient with sickle cell disease about reproduction : pregnancy outcome does not justify the maternal risk. Am J Obstet Gynecol 1971; 111: 324-7.
[4]
Rust Oa. Pregnancy complicated by sickle hemoglobinopathy. Clin Obstet Gunecol 1995; 38: 462-84.
[5]
Sun Pm, Wilburn W, Raynor Bd, Jamieson D. sickle cell disease in pregnancy: twenty years of experience at grady Memorial Hospital, Atlanta, Geaorgia. Am J Obstet Gynecol. 2001; 184: 1127-30.
[6]
Vidal Recos. Acute pyelonephritis in adults. www.vidalrecos.fr/pages/reco.php?defche=153187
[7]
Leborgne-Samuel Y, Kadhel P, Ryan C, Vendittelli F. Sickle cell disease and pregnancy. Rev Prat 2004, 30 ; 54 : 1578-82
[8]
Bruni D, Wigfall Dr, Zimmerman Sa, Rasoff Pm, Wiener Js. Genitourinary complications of sickle cell disease. J Urol 2001, 166; 3 803-11
[9]
De Pont Ac, Wolf H, Van Delden Om, De Reijke Tm. Pyelonephritis during pregnancy: a threat to mother and child. Ned TTijdschr Geneeskd 2008, 5; 152: 58.
[10]
Meyrier Alain Pyélonéphrites aiguës: infections of the urinary tract. Rev Prat 2003, 53 ; 16 : 1777-84.
[11]
Acute pyelonephritis. Randomised double-blind comparison of ciprofloxacin and tobramycin. www.spc.univ-lyon.fr/lecture-critique/TP/travail_sur_article/infection_urinaire/article.htlm-20k
[12]
Howard Rj. Management of sickling conditions in pregnancy. Br J Hosp Med 1996; 56: 7 – 10.
[13]
Podard D, Maude G, Plant M, Scorer H, Serjeant G. Pregnancy in Jamaican women with homozygous sickle cell disease. Fetal and maternal outcome. Br J Obstet Gynecol 1986; 93: 927-32.
[14]
Stefanescu D. Sickle cell disease and pregnancy. Doctorat Thesis. Université René-Descartes (Paris VI) 2001 : 11.
[15]
Anonymous. Hemoglobinopathies in pregnancy. Int J Gynecol Obstet 1993 ; 43 : 333-42.
[16]
Ataga Ki, Orringer Ep. Renal abnormalities in sickle cell disease. Am J Hematol. 2000; 63: 205-11.
[17]
Remy P. Renal complications of sickle cell disease. In La Drépanocytose, 2003 : 117-123
Browse journals by subject